Cover Image

Severe exacerbations of chronic obstructive pulmonary disease: management with noninvasive ventilation on a general medicine ward

Sirio Fiorino, Eugenio Detotto, Michele Battilana, Letizia Bacchi-Reggiani, Renzo Moretti, Furio Benfenati, Adriana Caselli, Serena Marchi, Maria R. Testi, Claudio G. Gallo, Andrea Cuppini, Giuseppe Kindt, Maurizio Moretti
  • Eugenio Detotto
    Affiliation not present
  • Michele Battilana
    Affiliation not present
  • Letizia Bacchi-Reggiani
    Affiliation not present
  • Renzo Moretti
    Affiliation not present
  • Furio Benfenati
    Affiliation not present
  • Adriana Caselli
    Affiliation not present
  • Serena Marchi
    Affiliation not present
  • Maria R. Testi
    Affiliation not present
  • Claudio G. Gallo
    Affiliation not present
  • Andrea Cuppini
    Affiliation not present
  • Giuseppe Kindt
    Affiliation not present
  • Maurizio Moretti
    Affiliation not present

Abstract

Introduction: Recent evidence suggests that, with a well-trained staff, severe exacerbations of chronic obstructive pulmonary disease (COPD) with moderate respiratory acidosis (pH > 7.3) can be successfully treated with noninvasive mechanical ventilation (NIMV) on a general respiratory care ward. We conducted an open prospective study to evaluate the efficacy of this approach on a general medicine ward.
Material and methods: This study population consisted in 27 patients admitted to a general medicine ward (median nurse:patient ratio 1:12) December 1, 2004 May 31, 2006 for acute COPD exacerbation with hypercapnic respiratory failure and acidosis (arterial pH < 7.34, PaC02 > 45 mmHg). All received assist-mode NIMV (average 12 h / day) via oronasal masks (inspiratory pressure 10-25 cm H2O, expiratory pressure 4-6 cm H2O) to maintain O2 saturation at 90-95%. Treatment was supervised by an experienced pulmonologist, who had also provided specific training in NIMV for medical and nursing staffs (90-day course followed by periodic refresher sessions). Arterial blood pressure, O2 saturation, and respiratory rate were continuously monitored during NIMV. Based on baseline arterial pH, the COPD was classified as moderate (7.25-7.34) or severe (< 7.25).
Results: In patients with moderate and severe COPD, significant improvements were seen in arterial pH after 2 (p < 0.05) and 24 h (p< 0.05) of NIMV and in the PaC02 after 24 hours (p < 0.05). Four (15%) of the 27 patients died during the study hospitalization (in-hospital mortality 15%), in 2 cases due to NIMV failure. For the other 23, mean long-term survival was 14.5 months (95% CI 10.2 to 18.8), and no significant differences were found between the moderate and severe groups. Over half (61%) the patients were alive 1 year after admission.
Conclusions: NIMV can be a cost-effective option for management of moderate or severe COPD on a general medicine ward. Its proper use requires: close monitoring of ventilated subjects, optimum staff:patient ratio, well-trained staff dedicated to NIMV, and supervision by a pulmonologist with experience in NIMV. The treatment was effective at improving arterial blood gases in both groups of COPD patients. The severity of the COPD did not significantly affect length of hospital stay, in-hospital mortality, or long-term survival.

Keywords

Noninvasive mechanical ventilation (NIMV); Chronic obstructive pulmonary disease (COPD); Acute respiratory failure (ARF).

Full Text:

PDF
Submitted: 2013-04-26 14:01:04
Published: 2013-04-30 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
453

Views:
PDF
216

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2013 Sirio Fiorino, Eugenio Detotto, Michele Battilana, Letizia Bacchi-Reggiani, Renzo Moretti, Furio Benfenati, Adriana Caselli, Serena Marchi, Maria R. Testi, Claudio G. Gallo, Andrea Cuppini, Giuseppe Kindt, Maurizio Moretti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy